Page last updated: 2024-10-31

nafamostat and Carotid Stenosis

nafamostat has been researched along with Carotid Stenosis in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Carotid Stenosis: Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sawada, M1
Yanamoto, H1
Nagata, I1
Hashimoto, N1
Nakahara, I1
Akiyama, Y1
Kikuchi, H1
Macdonald, RL1

Other Studies

1 other study available for nafamostat and Carotid Stenosis

ArticleYear
Prevention of neointimal formation by a serine protease inhibitor, FUT-175, after carotid balloon injury in rats.
    Stroke, 1999, Volume: 30, Issue:3

    Topics: Animals; Benzamidines; Carotid Stenosis; Guanidines; Male; Rats; Rats, Sprague-Dawley; Serine Protei

1999